In the most recent trading session, Synopsys (SNPS) closed at $514.49, indicating a -1% shift from the previous trading day.
The latest trading day saw Synopsys (SNPS) settling at $480.42, representing a +2.28% change from its previous close.
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Synopsys (SNPS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Synopsys NASDAQ: SNPS has turned the corner after a year of uncertainty. The company's guidance for Q4 fiscal year 2026 (FY2026) reveals accelerating integration of its services and stabilization of the business.
SNPS posts a Q4 beat as revenues surge on strong Time-Based, Upfront Product and EDA growth, while offering upbeat FY26 and Q1 outlooks.
Synopsys Inc (NASDAQ:SNPS, XETRA:SYP) has been upgraded by Bank of America to ‘Buy' from ‘Neutral,' with the firm pointing to better-than-expected fiscal 2026 earnings guidance and reduced risk tied to China and Intel. The firm also raised its price objective on the chip design firm to $560 from $500, above current levels of about $478.
Synopsys, Inc. (SNPS) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Synopsys (SNPS) give a sense of how its business performed in the quarter ended October 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synopsys (SNPS) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.79 per share. This compares to earnings of $3.4 per share a year ago.
All this dealmaking, much of which is quite circular, in the AI scene of late has really taken the AI bubble fears of some to the next level.
Bank of America upgraded Synopsys Inc (NASDAQ:SNPS, XETRA:SYP) to “Neutral” on Monday, saying the chip-design software maker's upcoming earnings call will be critical for rebuilding investor confidence after a weak patch in its intellectual property business and uncertainty tied to its Ansys acquisition. The brokerage raised its rating from “Underperform” but trimmed its price objective to $500 from $525, reflecting a 4% cut to its fiscal 2026 and 2027 earnings estimates.